For instance, GSDME mRNA levels in skin biopsies of psoriasis patients declined on Day 15 after Brodalumab biological agents, through analyzing GSE53552 from Russell’s study [27] (Fig. 1G). This evidence concerns the gene GSDME and psoriasis.